COVID-19: A Global Threat to the Nervous System

COVID-19: A Global Threat to the Nervous System

Authors: Igor J. Koralnik MD,Kenneth L. Tyler MD 07 June 2020 Annals of NeurologyVolume 88, Issue 1 p. 1-11 AbstractIn less than 6 months, the severe acute respiratory syndrome-coronavirus type 2 (SARS-CoV-2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initia

Why Are So Many People Getting COVID a Second and Third Time?

Why Are So Many People Getting COVID a Second and Third Time?

Doctors say if you got infected with the Omicron BA.1 or BA.2 variants, your antibodies might not fully protect you against the newer BA.4 and BA.5 subvariants now spreading through Southern CaliforniaAuthors: Joel Grover and Josh Davis June 16, 2022 NBC NewsA sign encouraging mask use hangs on a

This May Be the COVID Variant Scientists Are Dreading

This May Be the COVID Variant Scientists Are Dreading

Authors: David Axe June 20, 2022 TDBCOVID-19 cases are increasing again in the United Kingdom, potentially signaling a future surge in infections in the United States and other countries.A pair of new subvariants of the dominant Omicron variant—BA.4 and BA.5—appear to be driving the uptick in cas

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , *Front Immunol. 2022; 13: 857573. Apr 27. 2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561AbstractSevere acute respiratory sy

Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results

Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results

Authors: Mimi Nguyen Ly June 16, 2022 The Epoch TimesPaxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters)Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its C

Mask mandate and use efficacy in state-level COVID-19 containment

Mask mandate and use efficacy in state-level COVID-19 containment

Authors: Damian D. Guerra, Daniel J. Guerra doi: https://doi.org/10.1101/2021.05.18.21257385AbstractBackground Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission. Because COVID-19 can spread via respired droplets, many states have mandated mask use in publ

Severe COVID ‘Rare’ in People Who Didn’t Get Vaccine, Survey Reveals

Severe COVID ‘Rare’ in People Who Didn’t Get Vaccine, Survey Reveals

A survey of 300,000 people who didn’t get the COVID-19 vaccine revealed the unvaccinated didn’t place a disproportionate burden on health systems — in fact, they experienced very low rates of hospitalization and severe COVID-19.Authors: Alliance for Natural Health International 06/09/22There hav

24 Questions to Ask Your Doctor About the COVID-19 Vaccine

24 Questions to Ask Your Doctor About the COVID-19 Vaccine

Experts address vaccination and children, safety, side effects, boosters, variants and long COVID.Authors: Lisa EspositoThe COVID-19 vaccine has been publicly available in the U.S. since December 2020. Since then, vaccination has eased the pandemic by preventing infections, reducing severe disease

What’s Graphene Oxide?

What’s Graphene Oxide?

Is a toxic material hiding inside the COVID vaccines causing blood clots?Authors: Emerald Robinson Jun 13, 2022 As more and more people around the world share their stories of COVID vaccine injuries, the inevitable question becomes: what’s really in the experimental shots? This is not an academi